database Mar 30, 2022 ConcertAI Nets $150M Investment to Advance Software Solutions for Cancer Drug Trials Feb 3, 2022 Castle Biosciences Working With NCI on SEER Registry Study of DecisionDx-Melanoma Jan 26, 2022 Flatiron Health, Japanese Hospital Partner on Real-World GI Cancer Database Oct 7, 2021 FDA Recognizes Portion of MSK Oncology Knowledge Base in Public Human Genetic Variant Database Sep 28, 2021 Growing Texas ACCESS Database Fueling Research Into Pediatric Cancer Genomics Premium Sep 10, 2021 Clinical Trial Matching Startup's Survey Spotlights NGS Access Barriers, Patient Awareness Premium Sep 9, 2021 Cedars-Sinai, Tempus Partner on Molecular Database Initiative Aug 12, 2021 Australian Researchers Develop Tool to Support Physicians' Precision Oncology Treatment Decisions Premium Jul 15, 2021 Cota, MedStar Health Ink Real-World Data Research Partnership Apr 15, 2021 AACR Project GENIE Enables Analysis of Growing Actionability, Disparities in Precision Oncology Premium Mar 24, 2021 NCI's Sharpless Calls Data Science 'Critical' to Cancer Research, Precision Oncology Premium Sep 10, 2020 Syapse, Amita Health Cancer Institute Partner to Build Real-World Database Sep 3, 2020 Indivumed Expands Global Network, Multiomics Database Jan 28, 2020 Predictive Technology Group, Atrin Pharmaceuticals Launch Oncology MDx Collaboration Jan 13, 2020 Taproot's Master Observational Trial Attempting to Gather Missing Outcomes Data in Precision Oncology Premium Aug 7, 2019 Pediatric Cancer Researchers, Clinicians Look to Enhance Molecular Data Collection, Distribution Jun 25, 2019 Pediatric Cancer Big Data Initiatives Could Help Set Best Practices for Sequencing, Data Sharing Premium Jun 4, 2018 At ASCO, FDA Discusses Use of Real-World Data Drawn From Flatiron Health's Clinico-Genomics Database Premium Jan 16, 2018 CMS Approves CureOne Registry to Collect MIPS-Related Metrics Around Cancer Molecular Testing Premium Jun 5, 2017 Foundation Medicine, Flatiron Health Show Utility of Clinico-Genomic Database at ASCO Premium Breaking News European Commission Approves Libtayo in PD-L1-Positive Non-Small Cell Lung Cancer NICE Backs Merck's Keytruda for PD-L1-Expressing Cervical Cancer Genialis Closes $13M Series A Funding Round Breast Cancer Study Leads to New Susceptibility Gene, Potential Treatment Strategies Incyte's Pemazyre Approved in Japan for FGFR1-Positive Rare Blood Cancers Cardiff Oncology Begins Phase II Onvansertib Trial in KRAS-, NRAS-Mutant Colorectal Cancer
